Literature DB >> 7778177

Human lymphocytotoxic monoclonal autoantibodies from a highly sensitized renal dialysis patient.

M M Robledo1, J Melero, L Dinca, D Tarragó, J R García-Lozano, A Núñez-Roldán, B Sánchez.   

Abstract

A panel of 5 human monoclonal autolymphocytotoxic antibodies (IRM-3, IRM-4, IRM-7, IRM-8, and IRM-10) of the IgM class was established from a highly sensitized renal dialysis patient (IRM), by the generation of mouse-human heterohybridomas. This panel was screened for reactivity against foreign and autoantigens by ELISA, and for reactivity against different tissue sections and HEp-2 slide preparations by indirect immunofluorescence. Cytotoxicity screening of heterohybridoma supernatants gave broad panel reactivity profiles, being cytotoxic against B cells from patient IRM and also against most B cells tested and less reactive with chronic lymphocytic leukemia B cells; T cells were the least sensitive target. Immunoblotting showed that monoclonal IRM displayed some heterogeneity in their binding profiles, although all of them recognized a cellular structure of 26 kDa. None of the heterohybridoma cell lines exhibited cytoplasmic nor surface staining with an anti-CD5 mAb. Results obtained showed that all the autolymphocytotoxic mAbs generated were also able to react against certain nuclear and cytoplasmic self-structures as well as foreign compounds. Monoclonal antibody IRM-7 and, to a lesser degree, IRM-10 exhibited multispecific properties similar to those observed for polyreactive or natural antibodies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7778177

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

1.  Molecular structure of eight human autoreactive monoclonal antibodies.

Authors:  I Aguilera; J Melero; A Nuñez-Roldan; B Sanchez
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

2.  Identification of cation-independent mannose 6-phosphate receptor/insulin-like growth factor type-2 receptor as a novel target of autoantibodies.

Authors:  D Tarrago; I Aguilera; J Melero; I Wichmann; A Nuñez-Roldan; B Sanchez
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.